Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Adriamycin
Alymsys
Avastin
Cabometyx
Cisplatin
Cyramza
Doxorubicin
Imfinzi
Imjudo
Keytruda
Keytruda Qlex
Lenvima
Mitomycin
Mvasi
Nexavar
Opdivo
Sorafenib
Stivarga
Tecentriq
Tecentriq Hybreza
Transarterial Chemoemobilization
Vegzelma
Vitrakvi
Yervoy
Zirabev
Liver cancer is cancer that begins in the cells of your liver. The most common type of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte). (Source: Mayo Clinic)
Eligibility Criteria
Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Medications Covered
Adriamycin
Alymsys
Avastin
Cabometyx
Cisplatin
Cyramza
Doxorubicin
Imfinzi
Imjudo
Keytruda
Keytruda Qlex
Lenvima
Mitomycin
Mvasi
Nexavar
Opdivo
Sorafenib
Stivarga
Tecentriq
Tecentriq Hybreza
Transarterial Chemoemobilization
Vegzelma
Vitrakvi
Yervoy
Zirabev
Disease Description
Liver cancer is cancer that begins in the cells of your liver. The most common type of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte). (Source: Mayo Clinic)